Literature DB >> 18611736

Susceptibility surveillance of U.S. respiratory pathogen isolates to newer macrolide and azalide antibiotics.

S Brown1, A L Barry, P Burton.   

Abstract

Azithromycin and clarithromycin are both highly active in vitro against Gram-positive respiratory pathogens, but azithromycin is substantially more potent against Haemophilus influenzae. We investigated the susceptibility of H. influenzae, Moraxella catarrhalis, Streptococcus pneumoniae and S. pyogenes to azithromycin and clarithromycin, and determined the prevalence of beta-lactamase production in H. influenzae and M. catarrhalis. Results from three geographic regions of the USA were compared. A significantly greater proportion of H. influenzae isolates were susceptible to azithromycin than to clarithromycin (95.7% vs 63.1%, P < 0.001). M. catarrhalis, S. pneumoniae and S. pyogenes were highly susceptible to both antibiotics with no significant differences in susceptibility. beta-Lactamase was produced by 94.8% of M. catarrhalis isolates and 35.6% of H. influenzae.

Entities:  

Year:  1996        PMID: 18611736     DOI: 10.1016/0924-8579(96)00010-6

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

Review 1.  Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.

Authors:  H D Langtry; R N Brogden
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 2.  Azithromycin. A review of its use in paediatric infectious diseases.

Authors:  H D Langtry; J A Balfour
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.